Nasdaq:US$13.52 (+0.04) | HKEX:HK$20.72 (+0.04) | AIM:£1.97 (+0.04)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility